INOSI Trademark

Trademark Overview


On Sunday, March 26, 2023, a trademark application was filed for INOSI with the United States Patent and Trademark Office. The USPTO has given the INOSI trademark a serial number of 79368273. The federal status of this trademark filing is REGISTERED as of Tuesday, April 30, 2024. This trademark is owned by Inosi Therapeutics Pty Ltd. The INOSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of fibrosis, inflammatory and autoimmune disorders, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, pulmonary fibrosis, vascular fibrosis and cardiac fibrosis; pharmaceutical preparations for use in the treatment of systemic sclerosis, Sjogren's syndrome, Rheumatoid arthritis, and systemic lupus erythematosus; pharmaceutical preparations for use in the treatment of cancer and radiation induced lung injury; pharmaceutical preparations for use in the treatment of idiopathic pulmonary fibrosis, and pulmonary arterial hypertension; pharmaceutical preparations for use in the treatment of nonalcoholic steatohepatitis (NASH), fatty liver diseases and disorders and steatohepatitis and other related diseases and disorders
inosi

General Information


Serial Number79368273
Word MarkINOSI
Filing DateSunday, March 26, 2023
Status700 - REGISTERED
Status DateTuesday, April 30, 2024
Registration Number7369832
Registration DateTuesday, April 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of fibrosis, inflammatory and autoimmune disorders, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, pulmonary fibrosis, vascular fibrosis and cardiac fibrosis; pharmaceutical preparations for use in the treatment of systemic sclerosis, Sjogren's syndrome, Rheumatoid arthritis, and systemic lupus erythematosus; pharmaceutical preparations for use in the treatment of cancer and radiation induced lung injury; pharmaceutical preparations for use in the treatment of idiopathic pulmonary fibrosis, and pulmonary arterial hypertension; pharmaceutical preparations for use in the treatment of nonalcoholic steatohepatitis (NASH), fatty liver diseases and disorders and steatohepatitis and other related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInosi Therapeutics Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type81 - NOT AVAILABLE
AddressAU

Party NameInosi Therapeutics Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type81 - NOT AVAILABLE
AddressAU

Party NameInosi Therapeutics Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type81 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Thursday, April 27, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, May 13, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, January 24, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 24, 2024NOTICE OF PUBLICATION
Wednesday, January 24, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, May 4, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, May 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 20, 2023ASSIGNED TO EXAMINER
Monday, January 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Thursday, May 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, August 10, 2024NOTIFICATION PROCESSED BY IB
Friday, July 19, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 14, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 30, 2024REGISTERED-PRINCIPAL REGISTER
Friday, July 19, 2024FINAL DISPOSITION NOTICE SENT TO IB